Natsuko Morita

Osaka University of Pharmaceutical Sciences

Papers

1

Total Citations

2

H-Index

1

About

Natsuko Morita is a leading gynecologic oncologist whose research focuses on refining surgical approaches for early-stage cervical cancer, with a particular emphasis on sentinel lymph node biopsy (SNB) and minimally invasive techniques. Her most-cited work, "Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node Biopsy" (2024), addresses a critical gap in the literature by comparing oncological outcomes in patients undergoing SNB versus conventional lymphadenectomy. This study provides essential evidence that SNB may offer comparable safety while reducing surgical morbidity, potentially reshaping clinical guidelines. Morita’s contributions are especially impactful in advancing personalized, less invasive cancer care, and her work has already garnered attention within the field. By systematically evaluating sentinel node mapping—the first gateway for metastatic spread—she helps clarify its role in preserving oncologic integrity while improving patient recovery. Her research stands at the intersection of surgical innovation and evidence-based oncology, making her a key voice in the ongoing evolution of cervical cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node Biopsy
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Osaka University of Pharmaceutical Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago